Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.
Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.
NDC 
Symbiotica delivers high-quality APIs through advanced R&D, GMP-certified manufacturing, & trusted global pharmaceutical partnerships.
NDC
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
Axplora is your partner of choice for complex APIs.
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
HRV Pharma - Market Expansion Leader in Pharmaceuticals.
Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.
Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - 20MG/ML
USFDA APPLICATION NUMBER - 11757
DOSAGE - INJECTABLE;INJECTION - 40MG/ML
USFDA APPLICATION NUMBER - 11757
DOSAGE - INJECTABLE;INJECTION - 80MG/ML
USFDA APPLICATION NUMBER - 11757
Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dr. Paul Lohmann GmbH & Co. KGaA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gloria Interchem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Solubilizers
Topical
Film Formers & Plasticizers
Surfactant & Foaming Agents
Emulsifying Agents
Thickeners and Stabilizers
API Stability Enhancers
Lubricants & Glidants
Co-Processed Excipients
Direct Compression
Rheology Modifiers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
64
PharmaCompass offers a list of Methylprednisolone Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Methylprednisolone Acetate manufacturer or Methylprednisolone Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Methylprednisolone Acetate manufacturer or Methylprednisolone Acetate supplier.
A Methyl prednisolone acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Methyl prednisolone acetate, including repackagers and relabelers. The FDA regulates Methyl prednisolone acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Methyl prednisolone acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Methyl prednisolone acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Methyl prednisolone acetate supplier is an individual or a company that provides Methyl prednisolone acetate active pharmaceutical ingredient (API) or Methyl prednisolone acetate finished formulations upon request. The Methyl prednisolone acetate suppliers may include Methyl prednisolone acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Methyl prednisolone acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Methyl prednisolone acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Methyl prednisolone acetate active pharmaceutical ingredient (API) in detail. Different forms of Methyl prednisolone acetate DMFs exist exist since differing nations have different regulations, such as Methyl prednisolone acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Methyl prednisolone acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Methyl prednisolone acetate USDMF includes data on Methyl prednisolone acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Methyl prednisolone acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Methyl prednisolone acetate suppliers with USDMF on PharmaCompass.
A Methyl prednisolone acetate CEP of the European Pharmacopoeia monograph is often referred to as a Methyl prednisolone acetate Certificate of Suitability (COS). The purpose of a Methyl prednisolone acetate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Methyl prednisolone acetate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Methyl prednisolone acetate to their clients by showing that a Methyl prednisolone acetate CEP has been issued for it. The manufacturer submits a Methyl prednisolone acetate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Methyl prednisolone acetate CEP holder for the record. Additionally, the data presented in the Methyl prednisolone acetate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Methyl prednisolone acetate DMF.
A Methyl prednisolone acetate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Methyl prednisolone acetate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Methyl prednisolone acetate suppliers with CEP (COS) on PharmaCompass.
A Methyl prednisolone acetate written confirmation (Methyl prednisolone acetate WC) is an official document issued by a regulatory agency to a Methyl prednisolone acetate manufacturer, verifying that the manufacturing facility of a Methyl prednisolone acetate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Methyl prednisolone acetate APIs or Methyl prednisolone acetate finished pharmaceutical products to another nation, regulatory agencies frequently require a Methyl prednisolone acetate WC (written confirmation) as part of the regulatory process.
click here to find a list of Methyl prednisolone acetate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Methyl prednisolone acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Methyl prednisolone acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Methyl prednisolone acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Methyl prednisolone acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Methyl prednisolone acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Methyl prednisolone acetate suppliers with NDC on PharmaCompass.
Methyl prednisolone acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Methyl prednisolone acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Methyl prednisolone acetate GMP manufacturer or Methyl prednisolone acetate GMP API supplier for your needs.
A Methyl prednisolone acetate CoA (Certificate of Analysis) is a formal document that attests to Methyl prednisolone acetate's compliance with Methyl prednisolone acetate specifications and serves as a tool for batch-level quality control.
Methyl prednisolone acetate CoA mostly includes findings from lab analyses of a specific batch. For each Methyl prednisolone acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Methyl prednisolone acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Methyl prednisolone acetate EP), Methyl prednisolone acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Methyl prednisolone acetate USP).
